Browsing by Author Haywood, P

Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
24-Jan-2017Use and outcomes of targeted therapies in early and metastatic HER2–positive breast cancer in Australia: Protocol detailing observations in a whole of population cohortDaniels, B; Lord, S; Kiely, B; Houssami, N; Lu, C; Ward, R; Haywood, P; Pearson, S
2017Long-term health care costs for patients with prostate cancer: A population-wide longitudinal study in New South Wales AustraliaCronin, PA; Kirkbidge, B; Bang, A; Smith, D; Parkinson, B; Haywood, P
2017Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort studyPearce, AM; Haas, M; Viney, R; Pearson, S-A; Haywood, P; Brown, C; Ward, R
2017The effectiveness and cost-effectiveness of mandatory folic acid and iodine fortification. A report for the Australian Health Ministers’ Advisory CouncilHaywood, P; Goodall, S; Chinchen, E; Haas, M; Manipis, K; Meshcheriakova, O; Saing, S; van der Linden, N
2014Rates of chemotherapy adverse event in clinical practice: results from a prospective cohort studyPearce, AM; Haas, M; Viney, R; Pearson, S; Haywood, P; Ward, R
Jan-2012Delays in access to affordable medicines: putting policy into perspectivePearce, AM; Van Gool, K; Haywood, P; Haas, MR
Jan-2012Title:Chemotherapy administration: modelling the costs of alternative protocols..Haywood, P; de Raad, J; Van Gool, K; Haas, MR; Gallego, G; Pearson, S; Faedo, M; Ward, RL
Jan-2010Nursing takes time: Workload associated with administering cancer protocolsde Raad, J; Van Gool, K; Haas, MR; Haywood, P; Faedo, M; Gallego, G; Pearson, S; Ward, R
Jan-2005Alternatives to for-profit corporatisation: The view from general practiceAnderson, R; Haywood, P; Usherwood, T; Haas, MR; Hall, JP
Jan-2003Theory versus empiricism in health economics: as analysis of the past 20 yearsBridges, JF; Haywood, P
Jan-2002Diagnosis and prognosis of Australia's health information for evidence based policyVan Gool, K; Lancsar, E; Viney, RC; Hall, JP; Haywood, P